Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation.

Adults with acute lymphoblastic leukemia who underwent allogeneic transplant were evaluated for measurable residual disease with the clonoSEQ assay before and after transplant.

Blood AdvancesPubMed 37196642DOI 10.1182/bloodadvances.2023009856